Elevance Health (ELV) Long-Term Investments (2009 - 2026)

Elevance Health (ELV) has 18 years of Long-Term Investments data on file, last reported at $11.0 billion in Q1 2026.

• Quarterly Long-Term Investments rose 8.28% year-over-year to $11.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.0 billion (up 8.28% YoY) and the FY2025 annual result came in at $10.8 billion, up 947.25% from the prior year.
• Long-Term Investments improved to $11.0 billion in Q1 2026 per ELV's latest filing, from $10.8 billion in the prior quarter.
• Across five years, Long-Term Investments topped out at $11.0 billion in Q1 2026 and bottomed at $467.0 million in Q2 2022.
• The 5-year median for Long-Term Investments is $1.0 billion (2024), against an average of $3.7 billion.
• The widest annual swing landed in 2023, when Long-Term Investments jumped 1043.55%; it then slumped 88.17% in 2025.
• Tracing ELV's Long-Term Investments over 5 years: stood at $581.0 million in 2022, then jumped by 50.77% to $876.0 million in 2023, then climbed by 18.15% to $1.0 billion in 2024, then surged by 947.25% to $10.8 billion in 2025, then increased by 1.57% to $11.0 billion in 2026.
• Per Business Quant, the three latest ELV Long-Term Investments figures stand at $11.0 billion (Q1 2026), $10.8 billion (Q4 2025), and $1.1 billion (Q3 2025).

Peer Comparison